Gennova's MRNA Vaccine To Come In Powder Form; Will Stay Stable At 2-8 �C

[email protected]27 Oct, 2021News

Gennova Biopharmaceuticals? Covid-19 jab HGCO19, based on the mRNA technology platform, will be a lyophilized vaccine or one that is based on freeze-drying. This should help store the vaccine at much higher temperatures than the stringent sub-zero temperatures required to maintain a stable cold chain for other mRNA vaccines globally. The lyophilized vaccine will come in a powder form and it will be mixed with diluents before administration.